46249-9
ClinicalVaccination take-response type
Definition
Most commonly this will be used in Smallpox vaccination context but can be used elsewhere. It is the term that reference the individuals response to the vaccination specifically indicating the virus replication has taken place and vaccination was successful. Answer1 Major-indicated the viral replication has occurred and vaccination was successful and considered to be protected with the development of a major reaction Answer2 Equivocal reaction which indicates immune suppression of viral replication, allergic reaction without production of immunity, incorrect vaccination technique or impotent vaccine.
LOINC 6-Axis Classification
Component
Vaccination take-response type
Property
Prid
Time Aspect
Pt
System
^Patient
Scale Type
Nom
Method Type
N/A
Details
Class
VACCIN
Order/Observation
Observation
Short Name
Vaccination take-response type
Related Names
Frequently Asked Questions
What is LOINC code 46249-9?
LOINC code 46249-9 identifies "Vaccination take-response type". Most commonly this will be used in Smallpox vaccination context but can be used elsewhere. It is the term that reference the individuals response to the vaccination specifically indicating the virus replication has taken place and vaccination was successful. Answer1 Major-indicated the viral replication has occurred and vaccination was successful and considered to be protected with the development of a major reaction Answer2 Equivocal reaction which indicates immune suppression of viral replication, allergic reaction without production of immunity, incorrect vaccination technique or impotent vaccine.
What does 46249-9 measure?
This code measures Vaccination take-response type in ^Patient. It belongs to the VACCIN class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.